FDA warns of increased risk of death with IV antibacterial Tygacil ()

Tygacil treats infections caused by bacteria. The FDA Drug Safety Communication has issued a warning of increased risk of death with IV antibacterial Tygacil (tigecycline) and is now requiring a boxed warning (highest warning) of increased death with Tygacil as compared to other drugs in the category. Tygacil should now only be used when all other choices have been exhausted.